Transfer and validation of bioanalytical method for detection of cabotegravir in RAT plasma
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $255,825
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 53% obligated
-
- $255,824.66 Current, with exercised options
- $481,814.66 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$55,505 | |
| Funding Only Action | -$38,208 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $75,907 | |
| Original award | $273,630 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Lovelace Biomedical Research Institute on August 1, 2019, with a ceiling value of $481,814.66 for transfer and validation of a bioanalytical method for detection of cabategravier in rat plasma, supporting comprehensive resources for HIV microbicides and biomedical prevention research.
The delivery order is issued under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ. Place of performance is Albuquerque, NM. The order has a cost-plus-fixed-fee pricing structure with an ultimate completion date of July 31, 2022.
Service Contract Inventory reporting through FY2022 shows a labor footprint of 0.6 FTEs across 1,211 contractor hours in the final reported year. The derived government-paid hourly rate rose from $54.51/hr in FY2021 to $207.09/hr in FY2022. Lovelace self-performed all reported hours with no subcontractors engaged.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $255,825 on 75N93019F00131. Its potential value, with all options, is $481,815.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201600009I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award